Monitoring left ventricular assist device parameters to detect flow- and power-impacting complications: a proof of concept
Authors:
- Mehran MoazeniMMMehran Moazeni
- Mehran MoazeniMMMehran Moazeni
- Lieke NumanLNLieke Numan
- Lieke NumanLNLieke Numan
- Niels P Van der KaaijNKNiels P Van der Kaaij
- Niels P Van der KaaijNKNiels P Van der Kaaij
- Folkert W AsselbergsFAFolkert W Asselbergs
- Folkert W AsselbergsFAFolkert W Asselbergs
- Linda W van LaakeLLLinda W van Laake
- Linda W van LaakeLLLinda W van Laake
Open Access
- 27 October 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 4 (6) , 488-495
Abstract
Aims: The number of patients on left ventricular assist device (LVAD) support increases due to the growing number of patients with end-stage heart failure and the limited number of donor hearts. Despite improving survival rates, patients frequently suffer from adverse events such as cardiac arrhythmia and major bleeding. Telemonitoring is a potentially powerful tool to early detect deteriorations and may further improve outcome after LVAD implantation. Hence, we developed a personalized algorithm to remotely monitor HeartMate3 (HM3) pump parameters aiming to early detect unscheduled admissions due to cardiac arrhythmia or major bleeding. Methods and results: The source code of the algorithm is published in an open repository. The algorithm was optimized and tested retrospectively using HeartMate 3 (HM3) power and flow data of 120 patients, including 29 admissions due to cardiac arrhythmia and 14 admissions due to major bleeding. Using a true alarm window of 14 days prior to the admission date, the algorithm detected 59 and 79% of unscheduled admissions due to cardiac arrhythmia and major bleeding, respectively, with a false alarm rate of 2%. Conclusion: The proposed algorithm showed that the personalized algorithm is a viable approach to early identify cardiac arrhythmia and major bleeding by monitoring HM3 pump parameters. External validation is needed and integration with other clinical parameters could potentially improve the predictive value. In addition, the algorithm can be further enhanced using continuous data.Keywords
Funding Information
- Health-Holland, Top Sector Life Sciences & Health (LSHM 19022, LVAD-LVAD LSHM19035)
This publication has 23 references indexed in Scilit:
- Initial experience with telemonitoring in left ventricular assist device patientsJournal of Thoracic Disease, 2019
- Advanced telemonitoring of Left Ventricular Assist Device patients for the early detection of thrombosisJournal of Network and Computer Applications, 2018
- Analysis of LVAD log files for the early detection of pump thrombosis2017
- A Fully Magnetically Levitated Circulatory Pump for Advanced Heart FailureNew England Journal of Medicine, 2017
- Remote hemodynamic monitoring for ambulatory left ventricular assist device patients2015
- Identification and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device SystemJACC: Heart Failure, 2015
- Blood Pressure and Adverse Events During Continuous Flow Left Ventricular Assist Device SupportCirculation: Heart Failure, 2015
- Medical device alarmsBiomedical Engineering / Biomedizinische Technik, 2011
- Increase in circadian variation after continuous-flow ventricular assist device implantationThe Journal of Heart and Lung Transplantation, 2010
- Predicting Hospitalization Due to Worsening Heart Failure Using Daily Weight Measurement: Analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) StudyEuropean Journal of Heart Failure, 2009